Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8921565 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

Patent 8921565 was granted and assigned to Deciphera Pharmaceuticals on December, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Deciphera Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8921565

Patent Inventor Names

Daniel L. Flynn0

Michael D. Kaufman0

Date of Patent

December 30, 2014

Patent Application Number

13683277

Date Filed

November 21, 2012

Patent Citations Received

‌

US Patent 12102620 Combination therapy for the treatment of mastocytosis

‌

US Patent 12023327 Methods of treating gastrointestinal stromal tumors

‌

US Patent 12059410 Methods of treating gastrointestinal stromal tumors

‌

US Patent 12059411 Methods of treating gastrointestinal stromal tumors

‌

US Patent 12064422 Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluoropheyl)-3-phenylurea

‌

US Patent 12071432 Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof

‌

US Patent 11679110 Methods of treating disorders using CSF1R inhibitors

‌

US Patent 11779572 Methods of treating gastrointestinal stromal tumors

...

Patent Primary Examiner

‌

James D. Anderson

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8921565 Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API